Cardiovascular complications of collagen vascular disease
- 68 Downloads
Collagen vascular diseases commonly affect the heart; cardiovascular events are the major cause of mortality in people with these diseases.
A striking feature of the cardiac involvement in individuals with systemic lupus erythematosus (SLE) and rheumatoid arthritis is aggressive and accelerated atherosclerosis; women with SLE in the 35-to 44-year-old age group are more than 50 times more likely to suffer myocardial infarction than are matched controls.
Traditional risk factors contribute to the accelerated atherosclerosis, but cannot explain the extent of risk. It is possible that the inflammatory process, which is similar to the inflammatory process in atherosclerosis, pays a critical pathophysiologic role.
It is critically important to identify the presence of traditional cardiovascular risk factors (eg, tobacco usage, hypertension, hypercholesterolemia, diabetes, homocysteinemia), and to modify these to secondary prevention targets.
Cardiac valvular disease is common in individuals with SLE and rheumatoid arthritis; its presence should be anticipated and subacute bacterial endocarditis prophylaxis precautions initiated.
Cardiac autonomic neuropathy and conduction disturbances are common in people with heart disease related to systemic sclerosis and human leukocyte antigen B27; these patients should be monitored carefully for evidence of dysrhythmias.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.Boumpas DT, Austin HA 3rd, Fessler BJ, et al.: Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Int Med 1995, 122:940–950. An excellent review of more than 400 articles describing recent advances and controversies in the diagnosis and management of SLE with visceral involvement.PubMedGoogle Scholar
- 2.Klemperer P, Pollack AD, Baehr G: Pathology of disseminated lupus erythematosus. Arch Pathol 1941, 32:569–631.Google Scholar
- 6.Crozier IG, Li E, Milne MJ, Nicholls MG: Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990, 65:1145–1148. This echocardiographic study demonstrates the frequency and characteristics of pericardial, valvular, and myocardial abnormalities detected in a series of 50 patients with SLE relative to matched controls.PubMedCrossRefGoogle Scholar
- 8.Cervera R, Font J, Pare C, et al.: Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheumatic Dis 1992, 51:156–159.Google Scholar
- 10.Louthrenoo W, Ruttanaumpawan P, Aramrattana A, Sukitawut W: Cardiovascular autonomic nervous system dysfunction in patients with rheumatoid arthritis and systemic lupus erythematosus. Q J Med 1999, 92:97–102.Google Scholar
- 20.Manzi S, Meilahn EN, Rairie JE, et al.: Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997, 145:408–415. These authors report the cardiovascular event rate and potential contributory factors in 498 women with SLE (3522 person-years) followed at the University of Pittsburgh Medical Center from 1980 to 1993. They stress the impact of accelerated atherosclerosis and the need for aggressive management of risk factors.PubMedGoogle Scholar
- 25.Kitas G, Banks MJ, Bacon PA: Cardiac involvement in rheumatoid disease. Clin Med 2001, 1:18–21. This is a detailed review of the pericardial disease, valvulitis, myocardial involvement, and coronary artery disease that accompany RA. The authors stress that cardiovascular disease, particularly coronary artery disease, occurs early and causes almost 50% of all RA deaths. Valvular and myocardial involvement is usually clinically silent.PubMedGoogle Scholar
- 33.Slack D, Waller B: Acute congestive heart failure due to the arteritis of rheumatoid arthritis. Early diagnosis by endomyocardial biopsy. Angiology 1986, 6:477–481.Google Scholar
- 35.Banks MJ, Flint EJ, Bacon PA, Kitas GD: Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum 2000, 43:S385.Google Scholar
- 36.Pasceri V, Yeh ETH: A tale of two diseases. Atherosclerosis and rheumatoid arthritis. Circulation 1999, 100:2124–2126. This editorial summarizes and compares data currently available describing the inflammatory and immunologic responses observed in atherosclerosis, unstable angina, and RA, pointing out striking similarities in macrophage, T cell, B cell, and mast cell activation as well as cytokine, adhesion molecule, and endothelin concentrations. The authors speculate that a common pathophysiologic process exists.PubMedGoogle Scholar
- 37.Kitas G, Banks MJ, Bacon PA: Accelerated atherosclerosis as a cause of cardiovascular death in rheumatoid arthritis. Pathogenesis 1998, 1:73–83.Google Scholar
- 38.Del Rincon ID, Williams K, Stern MP, et al.: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737–2745. The authors present data from the San Antonio Heart Study indicating a threefold greater incidence of cardiovascular disease in RA, and demonstrate that the increased risk is independent of traditional risk factors, suggesting that increased inflammatory activity or oxidative stress may be operative.PubMedCrossRefGoogle Scholar
- 41.Generini S, Fiori G, Moggi-Pignone A, et al.: Systemic sclerosis: a clinical overview. Advan Exper Med Biol 1999, 455:75–83. This chapter reviews the multiorgan system involvement of SSc, and presents a concise summary of scleroderma heart disease.Google Scholar
- 58.Rosada M, Cozzi F, Bullo A, et al.: Prevalence of ventricular late potentials in systemic sclerosis and analysis of clinical and 24 hour electrocardiography associations. Reumatismo 1997, 49(suppl_3):221.Google Scholar
- 61.Bergfeldt L: HLA-B27-associated cardiac disease. Ann Intern Med 1997, 127:621–629. The author summarizes available information about cardiac disease in relation to the immunogenetic marker HLA-B27 and its associated inflammatory disorders. He stresses that the heart and joints are both of major importance as targets for the HLA-B27-associated disease process, and that HLAB27 -related cardiac lesions may be found in the absence of other rheumatologic manifestations. He further suggests a genetically linked cardiac syndrome: the combination of conduction system abnormalities and aortic regurgitation.PubMedGoogle Scholar
- 64.Cruickshank B: Pathology of ankylosing spondylitis. Clin Orthop 1971, 74:43–58.Google Scholar
- 68.Hallegua DS, Wallace DJ: How accelerated atherosclerosis in SLE has changed our management of the disorder. Lupus 2000, 9:228–231. This article describes the accelerated atherosclerotic process and the importance of monitoring and treating the known risks factors, as well as the possible roles of homocysteine and antiphospholipid antibodies. The authors suggest a treatment algorithm to reduce the incidence of coronary artery disease in patients with SLE.PubMedCrossRefGoogle Scholar
- 69.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497. These are the most recent guidelines designed to identify risk factors for cardiovascular disease, allow risk assessment of individual patients based upon Framingham data, and provide treatment targets based upon overall risk.CrossRefGoogle Scholar
- 77.Konstam MA, Weir MR, Reicin A, et al.: Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation 2001, 104:r15-r23.Google Scholar